Centene said that it will appoint five new members to its board of directors, four of whom have already been named and the fifth yet to be named. Let’s find out about the new Execs.
- Ken Burdick: Mr. Burdick is a former vice president at Centene, where he helmed products and markets until retiring in January 2021. He joined Centene’s executive leadership team after it acquired WellCare, where he served for five years, according to Mr. Burdick’s LinkedIn profile.
- Christopher Coughlin: Mr. Coughlin’s background includes serving as a financial and operating leader at companies like Allergan, Alexion and Covidien, according to a news release from Centene. Most recently, as CFO of Tyco, he split the company into six entities to create shareholder value.
- Wayne DeVeydt: Before being appointed to his current position as executive chairman on Surgery Partners’ board, Mr. DeVeydt served as the provider’s CEO and director since 2018, according to Centene’s news release.
- Theodore Samuel: Mr. Samuel formerly served as the president at Capital Guardian Trust Co. and as a global equity portfolio manager at investment management firm Capital Group, according to the Centene news release.
- Shares of Centene Corp. CNC, -0.40% gained 0.4% in premarket trading on Monday after the managed care company announced that its CEO is stepping down, its board will have five new members, and it signed a cooperation agreement with Politan Capital Management, a hedge fund. Michael Neidorff will retire in 2022 from his role as chairman and CEO.
